HIV / AIDS in the News

PEPFAR to Distribute Breakthrough HIV Drug Lenacapavir - Mirage News

 

CVS Health Will Not Cover Twice-Yearly HIV PrEP Yeztugo for Now - POZ - Health, Life and HIV

 

Peppermint, Javier Muñoz urge lawmakers not to cut HIV/AIDS funding - Watermark Out News

 

Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug - NPR

 

Gilead joins U.S. to expand access to new HIV drug (GILD) - Seeking Alpha

 

U.S. State Department Facilitates Affordable Lenacapavir Access for HIV High-Burden Nations - Devdiscourse

 

US plans to bring Gilead HIV drug to market in high-burden HIV countries - Reuters

 

Gilead partners with PEPFAR to expand HIV prevention access - Investing.com

 

U.S. to bring Gilead’s HIV drug lenacapavir to high-burden countries - Investing.com

 

Gilead partners with PEPFAR to deliver HIV prevention drug to 2 million people - StreetInsider

 

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries - Yahoo Finance

 

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries - Business Wire

 

US plans to bring Gilead HIV drug to market in high-burden HIV countries - Colorado Springs Gazette

 

US Plans to Bring Gilead HIV Drug to Market in High-Burden HIV Countries - U.S. News & World Report

 

Evaluating Linkage to Care Among Patients With HIV Viremia in Los Angeles, California - Cureus

 

Gilead Sciences Plans Price Increases for HIV Drugs in State-Run AIDS Assistance Programs - geneonline.com

 

US plans to bring Gilead HIV drug to market in high-burden HIV countries - TradingView

 

HIV treatment advocates warn GOP ‘cuts will kill’ at Capitol rally - Washington Blade

 

PEPFAR needs direction. Here’s how the program can get back on track - George W. Bush Presidential Center

 

Protesters demand release of HIV funds ‘illegally’ withheld by Trump | USAID - The Guardian

 

Gilead urges people living with HIV to 'Choose U' in campaign touting long-term treatment success - Fierce Pharma

 

The EU has approved a vaccine that can prevent HIV - The World Economic Forum

 

The EU has approved a medication that can prevent HIV - The World Economic Forum

 

Advocacy is our power, ending the HIV epidemic is our goal - IDSA

 

Advocates share inspiring journeys at 2025 U.S. Conference on HIV/AIDS in Washington D.C. - WKEF

 

Real-World Experiences of People Living with HIV Prioritizing Their Well-Being - Gilead Sciences

 

Wistar Institute's iCure Consortium to Test Six Strategies in Bid to Find a Personalized HIV Cure - Precision Medicine Online

 

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV - Yahoo Finance

 

Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV - Stock Titan

 

Gilead Sciences Launches Choose U Campaign Spotlighting the Inspiring Experiences of People Living with HIV - Business Wire